Education
About Us
Working with TipRanks
Follow Us
Natural Alternatives International (NAII)
NASDAQ:NAII
NAII Stock Chart & Stats
$3.15
-$0.10(-2.33%)
At close: 4:00 PM EST
$3.15
-$0.10(-2.33%)
Day’s Range― - ―
52-Week Range$2.33 - $4.96
Previous CloseN/A
Volume2.89K
Average Volume (3M)10.40K
Market Cap
$16.06M
Enterprise Value$119.00M
Total Cash (Recent Filing)$3.75M
Total Debt (Recent Filing)$106.51M
Price to Earnings (P/E)―
Beta0.10
Next Earnings
May 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.42
Shares Outstanding6,176,778
10 Day Avg. Volume14,152
30 Day Avg. Volume10,400
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.29
Price to Sales (P/S)0.15
P/FCF Ratio8.42
Enterprise Value/Market Cap7.41
Enterprise Value/Revenue0.88
Enterprise Value/Gross Profit10.30
Enterprise Value/Ebitda-326.92
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified Business ModelNAII’s dual model — contract manufacturing for third-party brands plus its own branded products and proprietary ingredients — provides multiple durable revenue streams. Contract manufacturing creates sticky customer relationships and volume visibility; branded/IP sales offer upside from commercialization and margin expansion over time.
Positive Operating And Free Cash FlowConsistent positive operating cash flow and positive free cash flow demonstrate the business’s ability to generate internal liquidity despite accounting losses. That cash generation supports working capital, modest capex, and deleveraging efforts, improving resilience over the next several quarters.
Strong Recent Revenue ReboundA large TTM revenue rebound indicates recovery in demand and ability to scale production. A higher revenue base can improve fixed-cost absorption and create a platform for margin recovery if cost structure or product mix is optimized, supporting medium-term operational improvement.
Bears Say
Weak Profitability And Low Gross MarginVery low gross margins and sustained net losses limit the company’s capacity to fund SG&A, R&D, or marketing from operating profits. This structural margin pressure makes earnings recovery dependent on meaningful cost reductions or higher-margin product mix shifts, a multi-quarter challenge.
Rising Leverage And Reduced FlexibilityMaterial increase in debt relative to equity tightens financial flexibility and raises fixed interest obligations. Elevated leverage constrains ability to invest in growth initiatives, increases refinancing risk, and leaves less buffer against operating volatility over the next several quarters.
Credit Covenant Breach Required WaiverA covenant default that required a formal waiver signals recurring covenant risk and reliance on lender accommodation. Even though waived, such events often bring tighter monitoring and could limit strategic flexibility, capital access, or require covenant-driven actions in the medium term.
Natural Alternatives International News
NAII FAQ
What was Natural Alternatives International’s price range in the past 12 months?
Natural Alternatives International lowest stock price was $2.33 and its highest was $4.96 in the past 12 months.
What is Natural Alternatives International’s market cap?
Natural Alternatives International’s market cap is $16.06M.
When is Natural Alternatives International’s upcoming earnings report date?
Natural Alternatives International’s upcoming earnings report date is May 20, 2026 which is in 86 days.
How were Natural Alternatives International’s earnings last quarter?
Natural Alternatives International released its earnings results on Feb 13, 2026. The company reported -$0.425 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.425.
Is Natural Alternatives International overvalued?
According to Wall Street analysts Natural Alternatives International’s price is currently Overvalued.
Does Natural Alternatives International pay dividends?
Natural Alternatives International does not currently pay dividends.
What is Natural Alternatives International’s EPS estimate?
Natural Alternatives International’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Natural Alternatives International have?
Natural Alternatives International has 6,176,778 shares outstanding.
What happened to Natural Alternatives International’s price movement after its last earnings report?
Natural Alternatives International reported an EPS of -$0.425 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Natural Alternatives International?
Currently, no hedge funds are holding shares in NAII
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Natural Alternatives International
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Asia, and internationally. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
Technical Analysis
Nature's Sunshine Products
―
Hain Celestial
―
USANA Health
―
LifeVantage
―
FitLife Brands
―
Ownership Overview
17.16% Insiders
10.65% Mutual Funds
15.54% Other Institutional Investors
52.26% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---